Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Protein Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview 2022-2027:

The global protein therapeutics market size reached US$ 298.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 456.0 Billion by 2027, exhibiting a growth rate (CAGR) of 7.26% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Protein therapeutics refers to artificially synthesized protein-based medicines. They are fast-acting, potent medicines that deliver small protein molecules to the body in a specific amount. They usually consist of recombinant forms of naturally occurring proteins, such as monoclonal antibodies, insulin, fusion proteins, erythropoietin, interferon, human growth hormones (HGH) and follicle-stimulating hormones. They aid in treating chronic medical ailments, such as cancer, diabetes, neurodegenerative disorders and immunological, hematological, hormonal and genetic disorders. Various combination therapy drugs are also used with protein therapeutics that can be inhaled, injected or orally administered.

Global Protein Therapeutics Market Trends and Drivers:

The increasing prevalence of chronic medical ailments is one of the key factors driving the growth of the protein therapeutics market. In line with this, the rising awareness among the masses regarding the benefits of protein therapeutics, such as minimal risks of side effects and high efficiency, are contributing to the market growth. Monoclonal antibodies are being widely researched and used for the treatment of various viral and bacterial diseases and pharmaceutical companies are using protein therapeutics for drug discovery and development. The sudden outbreak of the coronavirus disease (COVID-19) is further providing growth opportunities to market players. For instance, Molecular Partners AG, a Switzerland-based clinical stage biotechnology company, is developing a new class of protein therapeutics, called DARPin®, to inhibit the proliferation of the virus.

The development of novel recombinant proteins, peptides, antibody-based drugs and plasma proteins is acting as other-growth inducing factors. These protein therapeutics are extensively used in replacement therapies to treat genetic and autoimmune disorders, such as dysfibrinogenemia, afibrinogenemia, and hypofibrinogenemia. Other factors, including extensive research and development (R&D) activities in the field of protein engineering, along with significant improvements in the healthcare infrastructure, are expected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global protein therapeutics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, therapy area and function.

Breakup by Product:

  • Monoclonal Antibodies (mAbs)
  • Human Insulin
  • Erythropoietin
  • Clotting Factors
  • Fusion Protein
  • Others
     

Breakup by Therapy Area:

  • Metabolic Disorders
  • Immunological Disorders
  • Hematological Disorders
  • Cancer
  • Hormonal Disorders
  • Genetic Disorders
  • Others
     

Breakup by Function:

  • Enzymatic and Regulatory Activity
  • Special Targeting Activity
  • Vaccines
  • Protein Diagnostics
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Amgen Inc., Abbott Laboratories, Abbvie Inc., Baxter International Inc., Biogen Inc., Csl Behring L.L.C. (CSL Limited), Eli Lilly and Company, F. Hoffmann-La Roche AG (Roche Holding AG), Johnson & Johnson, Merck & Co. Inc., Novo Nordisk A/S (Novo Holdings A/S) and Pfizer Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Product, Therapy Area, Function, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Amgen Inc., Abbott Laboratories, Abbvie Inc., Baxter International Inc., Biogen Inc., Csl Behring L.L.C. (CSL Limited), Eli Lilly and Company, F. Hoffmann-La Roche AG (Roche Holding AG), Johnson & Johnson, Merck & Co. Inc., Novo Nordisk A/S (Novo Holdings A/S) and Pfizer Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Protein Therapeutics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product
    6.1    Monoclonal Antibodies (mAbs)
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Human Insulin
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Erythropoietin
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Clotting Factors
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Fusion Protein
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Others
        6.6.1 Market Trends
        6.6.2 Market Forecast
7   Market Breakup by Therapy Area
    7.1    Metabolic Disorders
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Immunological Disorders
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Hematological Disorders
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Cancer
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Hormonal Disorders
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Genetic Disorders
        7.6.1 Market Trends
        7.6.2 Market Forecast
    7.7    Others
        7.7.1 Market Trends
        7.7.2 Market Forecast
8   Market Breakup by Function
    8.1    Enzymatic and Regulatory Activity
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Special Targeting Activity
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Vaccines
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Protein Diagnostics
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Amgen Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio 
           14.3.1.3 Financials 
           14.3.1.4 SWOT Analysis
        14.3.2    Abbott Laboratories
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials 
           14.3.2.4 SWOT Analysis
        14.3.3    Abbvie Inc.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio 
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Baxter International Inc.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio 
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Biogen Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio 
           14.3.5.3 Financials 
           14.3.5.4 SWOT Analysis
        14.3.6    Csl Behring L.L.C. (CSL Limited)
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio 
        14.3.7    Eli Lilly and Company
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials 
           14.3.7.4 SWOT Analysis
        14.3.8    F. Hoffmann-La Roche AG (Roche Holding AG)
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio 
           14.3.8.3 SWOT Analysis
        14.3.9    Johnson & Johnson
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials 
           14.3.9.4 SWOT Analysis
        14.3.10    Merck & Co. Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio 
           14.3.10.3 Financials 
           14.3.10.4 SWOT Analysis
        14.3.11    Novo Nordisk A/S (Novo Holdings A/S)
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio 
           14.3.11.3 Financials 
           14.3.11.4 SWOT Analysis
        14.3.12    Pfizer Inc.
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio 
           14.3.12.3 Financials 
           14.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Protein Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Protein Therapeutics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Protein Therapeutics Market: Breakup by Product (in %), 2021
Figure 4: Global: Protein Therapeutics Market: Breakup by Therapy Area (in %), 2021
Figure 5: Global: Protein Therapeutics Market: Breakup by Function (in %), 2021
Figure 6: Global: Protein Therapeutics Market: Breakup by Region (in %), 2021
Figure 7: Global: Protein Therapeutics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 8: Global: Protein Therapeutics (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Protein Therapeutics (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Protein Therapeutics (Human Insulin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Protein Therapeutics (Human Insulin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Protein Therapeutics (Erythropoietin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Protein Therapeutics (Erythropoietin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Protein Therapeutics (Clotting Factors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Protein Therapeutics (Clotting Factors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Protein Therapeutics (Fusion Protein) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Protein Therapeutics (Fusion Protein) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Protein Therapeutics (Other Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Protein Therapeutics (Other Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Protein Therapeutics (Metabolic Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Protein Therapeutics (Metabolic Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Protein Therapeutics (Immunological Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Protein Therapeutics (Immunological Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Protein Therapeutics (Hematological Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Protein Therapeutics (Hematological Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Protein Therapeutics (Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Protein Therapeutics (Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Protein Therapeutics (Hormonal Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Protein Therapeutics (Hormonal Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Protein Therapeutics (Genetic Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Protein Therapeutics (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Protein Therapeutics (Other Therapy Areas) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Protein Therapeutics (Other Therapy Areas) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Protein Therapeutics (Enzymatic and Regulatory Activity) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Protein Therapeutics (Enzymatic and Regulatory Activity) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Protein Therapeutics (Special Targeting Activity) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Protein Therapeutics (Special Targeting Activity) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Protein Therapeutics (Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Protein Therapeutics (Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Global: Protein Therapeutics (Protein Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Global: Protein Therapeutics (Protein Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: North America: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: North America: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: United States: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: United States: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Canada: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Canada: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Asia Pacific: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Asia Pacific: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: China: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: China: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Japan: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Japan: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: India: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: India: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: South Korea: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: South Korea: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Australia: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Australia: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Indonesia: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Indonesia: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Others: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Others: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Europe: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Europe: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Germany: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Germany: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: France: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: France: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: United Kingdom: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: United Kingdom: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Italy: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Italy: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Spain: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Spain: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Russia: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Russia: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Others: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Others: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Latin America: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Latin America: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Brazil: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Brazil: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Mexico: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Mexico: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Others: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Others: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Middle East and Africa: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 89: Middle East and Africa: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: Global: Protein Therapeutics Industry: SWOT Analysis
Figure 91: Global: Protein Therapeutics Industry: Value Chain Analysis
Figure 92: Global: Protein Therapeutics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Protein Therapeutics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Protein Therapeutics Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Protein Therapeutics Market Forecast: Breakup by Therapy Area (in Million US$), 2022-2027
Table 4: Global: Protein Therapeutics Market Forecast: Breakup by Function (in Million US$), 2022-2027
Table 5: Global: Protein Therapeutics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Protein Therapeutics Market Structure
Table 7: Global: Protein Therapeutics Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global protein therapeutics market was valued at US$ 298.0 Billion in 2021.

 

We expect the global protein therapeutics market to exhibit a CAGR of 7.26% during 2022-2027.

The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of protein therapeutics across numerous biotechnology companies for drug discovery and to inhibit the proliferation of the coronavirus disease.

The rising prevalence of chronic medical ailments, along with the increasing awareness towards the benefits of protein therapeutics, such as minimal risks of side effects and high efficiency, is primarily driving the global protein therapeutics market.

Based on the product, the global protein therapeutics market has been segmented into Monoclonal Antibodies (mAbs), human insulin, erythropoietin, clotting factors, fusion protein, and others. Among these, Monoclonal Antibodies (mAbs) currently hold the majority of the total market share.

 

Based on the therapy area, the global protein therapeutics market can be divided into metabolic disorders, immunological disorders, hematological disorders, cancer, hormonal disorders, genetic disorders, and others. Currently, metabolic disorders exhibit a clear dominance in the market.

On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global protein therapeutics market include Amgen Inc., Abbott Laboratories, Abbvie Inc., Baxter International Inc., Biogen Inc., Csl Behring L.L.C. (CSL Limited), Eli Lilly and Company, F. Hoffmann-La Roche AG (Roche Holding AG), Johnson & Johnson, Merck & Co. Inc., Novo Nordisk A/S (Novo Holdings A/S), and Pfizer Inc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4